Patient perspective: Financial toxicity is a barrier to clinical trials and personalized therapy in cholangiocarcinoma

J Surg Oncol. 2022 Nov;126(6):1011. doi: 10.1002/jso.27034. Epub 2022 Jul 27.

Authors

Jessica M Keilson¹, Stacie Lindsey², Melinda Bachini², Caroline R Medin¹, Alexandra Berk³, Sophia Cornew³, Shishir K Maithel¹

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
² Cholangiocarcinoma Foundation, Herriman, Utah, USA.
³ Invitae, San Francisco, California, USA.

PMID: 35894231
DOI: 10.1002/jso.27034

No abstract available

MeSH terms

Bile Duct Neoplasms* / pathology
Bile Ducts, Intrahepatic / pathology
Cholangiocarcinoma* / pathology
Clinical Trials as Topic
Financial Stress
Humans

Grants and funding

Abraham J. and Phyllis Katz Foundation